UCL Grand Challenge of Global Health

Subscribe to our email newsletter


Latest Global Health News

International UCL-led study prompts rethink on the rise of diabetes in cities

Publication date:

Cities Changing Diabetes

New research led by UCL for the Cities Changing Diabetes partnership shows socio-cultural factors including time pressure, commuting time and where you live play significant roles in diabetes vulnerability.

‘Dickensian’ lung disease rates on the rise in UK pensioners

Publication date:


The number of people diagnosed with bronchiectasis, a lung condition thought to be a ‘disease of the past’, has risen considerably in the past decade and now affects more than 1% of UK pensioners, finds a new study by UCL, University College London Hospitals (UCLH) NHS Foundation Trust, Imperial College London and the London School of Hygiene and Tropical Medicine. The research was funded by the Medical Research Council and National Institute for Health Research.

Withdrawing dementia drug doubles risk of nursing home placement

Publication date:


Withdrawing a commonly-prescribed Alzheimer’s disease drug from people in the advanced stages of the disease doubles their risk of being placed in a nursing home within a year, according to UCL research published today in The Lancet Neurology.

Higher risk of death for patients admitted to NHS hospitals at the weekend

Publication date:


Patients admitted to hospital at the weekend are more likely to be sicker and have a higher risk of death, compared with those admitted during the week, finds an analysis published in The BMJ this week.

Children of more caring, less controlling parents live happier lives

Publication date:

Mother and baby

A UCL-led lifelong study of people in England, Scotland and Wales has found that those who perceived their parents as more caring and less psychologically controlling during their childhood were likely to be happier and more satisfied throughout their lives.

Improving treatment for systemic amyloidosis

Publication date:

Whole body anterior amyloid scans of a patient with systemic amyloidosis, showing abundant amyloid in the liver before treatment and the almost complete absence of amyloid after a single dose of the new anti-SAP antibody.

A potential new approach to treat systemic amyloidosis, invented at UCL and being developed by GlaxoSmithKline (GSK), marks the start of a successful and innovative academic-industry collaboration.

UCL to coordinate £16m project to crack difficult disease areas

Publication date:

Scientist examines samples under a microscope

UCL has successfully coordinated a £16 million bid to work with the Medical Research Council (MRC), GSK and four other universities to improve scientists’ understanding of inflammatory and fibrotic diseases that present a serious burden to patients.

Search UCL News